Patent · US Expired

Anti-IL-12 antibodies and compositions

US7166285B2 · kind B2 · utility

21Cited by
11References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 28, 2004
Grant dateJan 23, 2007
Priority date
Expiry dateJul 30, 2025

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to an anti-IL-12 antibody, including isolated nucleic acids that encode an anti-IL-12 antibody, IL-12, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.